地西他滨

【Product Name】DACOGEN

[English common name] Decitabine

[Chinese common name] decitabine

[English name] Decitabine intermediates

[Chinese other name] decitabine

[Indications] This product is suitable for patients with moderate-risk-2 and high-risk initial and recurrent myelodysplastic syndrome (MDS) in the IPSS scoring system , including primary and secondary MDS, according to FAB classification. Subtypes: refractory anemia, refractory anemia with ring-shaped iron blasts, refractory anemia with excessive blasts, refractory anemia with blasts-transformation, chronic granule-monocytes leukemia.

[Usage and Dosage] 1. First dosing cycle: The recommended dose of this product is 15mg/m2, continuous intravenous infusion for more than 3 hours, once every 8 hours, for 3 consecutive days. Patients can use conventional antiemetics in advance.
2. Subsequent dosing cycle:
(1) Repeat one cycle every 6 weeks. It is recommended to repeat at least 4 cycles. However, patients with complete or partial remission can be treated for more than 4 cycles. If the patient can continue to benefit, continue to take the drug.
(2) Dose adjustment or delayed administration according to the blood laboratory test value: If the product is treated in the previous cycle, hematologic recovery (ANC≥1OOO/μL, platelet ≥50OOO/μL) takes more than 6 weeks. Then the treatment of the next cycle should be delayed.

[Storage] Sealed and placed in a cool place.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.